BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37244946)

  • 1. NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc.
    Meng S; Xia Y; Li M; Wu Y; Wang D; Zhou Y; Ma D; Ye J; Sun T; Ji C
    Sci Rep; 2023 May; 13(1):8606. PubMed ID: 37244946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.
    Feng L; Yan Q; Pan H; Shi W
    Immun Inflamm Dis; 2023 Feb; 11(2):e789. PubMed ID: 36840486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.
    Chen X; Lu T; Cai Y; Han Y; Ding M; Chu Y; Zhou X; Wang X
    Cell Mol Biol Lett; 2023 Apr; 28(1):32. PubMed ID: 37076815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.
    Cheng Y; Fu Y; Wang Y; Wang J
    Front Genet; 2020; 11():955. PubMed ID: 33061938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
    Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBXIP promotes gastric cancer
    Yang Z; Jiang X; Li D; Jiang X
    Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL.
    Han H; Fan G; Song S; Jiang Y; Qian C; Zhang W; Su Q; Xue X; Zhuang W; Li B
    Blood; 2021 Mar; 137(12):1603-1614. PubMed ID: 32967010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
    Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
    Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Miao W; Chen J; Jia L; Ma J; Song D
    Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The m
    Cheng M; Sheng L; Gao Q; Xiong Q; Zhang H; Wu M; Liang Y; Zhu F; Zhang Y; Zhang X; Yuan Q; Li Y
    Oncogene; 2019 May; 38(19):3667-3680. PubMed ID: 30659266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
    Du QY; Huo FC; Du WQ; Sun XL; Jiang X; Zhang LS; Pei DS
    Oncogene; 2022 Sep; 41(39):4420-4432. PubMed ID: 35987795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3 promotes cell cycle progression via m
    Li H; Zhong Y; Cao G; Shi H; Liu Y; Li L; Yin P; Chen J; Xiao Z; Du B
    Int J Biol Sci; 2022; 18(8):3223-3236. PubMed ID: 35637959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of METTL3-mediated m
    Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
    Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
    Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.